These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34277913)

  • 1. Photodistributed toxic epidermal necrolysis in association with lamotrigine and tanning bed exposure.
    Russomanno K; DiLorenzo A; Horeczko J; Deng M; Cardis M; Petronic-Rosic V; Johnson LS; Pasieka HB
    JAAD Case Rep; 2021 Aug; 14():68-71. PubMed ID: 34277913
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: "Photodistributed toxic epidermal necrolysis in association with lamotrigine and tanning bed exposure".
    Tjahjono L; Young K; Wanat K; Siegel D
    JAAD Case Rep; 2022 May; 23():164-165. PubMed ID: 35519799
    [No Abstract]   [Full Text] [Related]  

  • 3. Photodistributed Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification.
    McKinley BJ; Allen ME; Michels N
    Eur J Med Res; 2023 Jun; 28(1):188. PubMed ID: 37303053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodistributed Toxic Epidermal Necrolysis: Case Report and Review of Current Literature.
    Gaghan LJ; Coates MM; Crouse LN; Miedema J; Mervak JE; Ziemer CM
    JAMA Dermatol; 2022 Jul; 158(7):787-790. PubMed ID: 35507359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Effects of Mesenchymal Stem Cells on a Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Model.
    Park SY; Oh IY; Kim JH; Kim HJ; Seo B; Kwon OY; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
    J Korean Med Sci; 2020 Apr; 35(15):e130. PubMed ID: 32301297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.
    Borrelli EP; Lee EY; Descoteaux AM; Kogut SJ; Caffrey AR
    Epilepsia; 2018 Dec; 59(12):2318-2324. PubMed ID: 30395352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful dabrafenib transition after vemurafenib-induced toxic epidermal necrolysis in a patient with metastatic melanoma.
    Tahseen AI; Patel NB
    JAAD Case Rep; 2018 Oct; 4(9):930-933. PubMed ID: 30320198
    [No Abstract]   [Full Text] [Related]  

  • 10. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
    Noguchi Y; Takaoka M; Hayashi T; Tachi T; Teramachi H
    Epilepsia; 2020 Sep; 61(9):1979-1989. PubMed ID: 32761907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
    Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
    Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
    Ueta M
    Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lamotrigine and its relationship with Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Velázquez-Cárcamo EA; Rodríguez-Chávez Y; Méndez-Flores S; Domínguez-Cherit J
    Rev Med Inst Mex Seguro Soc; 2020 Apr; 58(2):202-205. PubMed ID: 34101565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
    Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
    J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor relevance of a lymphocyte proliferation assay in lamotrigine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Tang YH; Mockenhaupt M; Henry A; Bounoua M; Naldi L; Le Gouvello S; Bensussan A; Roujeau JC
    Clin Exp Allergy; 2012 Feb; 42(2):248-54. PubMed ID: 22092454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018.
    Sunaga Y; Kurosawa M; Ochiai H; Watanabe H; Sueki H; Azukizawa H; Asada H; Watanabe Y; Yamaguchi Y; Aihara M; Mizukawa Y; Ohyama M; Hama N; Abe R; Hashizume H; Nakajima S; Nomura T; Kabashima K; Tohyama M; Takahashi H; Mieno H; Ueta M; Sotozono C; Niihara H; Morita E; Kokaze A
    J Dermatol Sci; 2020 Dec; 100(3):175-182. PubMed ID: 33046331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.
    Lonjou C; Borot N; Sekula P; Ledger N; Thomas L; Halevy S; Naldi L; Bouwes-Bavinck JN; Sidoroff A; de Toma C; Schumacher M; Roujeau JC; Hovnanian A; Mockenhaupt M;
    Pharmacogenet Genomics; 2008 Feb; 18(2):99-107. PubMed ID: 18192896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.